Published in

Instituto Oswaldo Cruz, Ministério da Saúde, Memórias do Instituto Oswaldo Cruz., 3(108), p. 342-351, 2013

DOI: 10.1590/s0074-02762013000300013

Links

Tools

Export citation

Search in Google Scholar

The antimicrobial activity of lapachol and its thiosemicarbazone and semicarbazone derivatives

Journal article published in 2013 by Nívea Pereira de Sá, Alves,Tania Maria de Almeida, Elaine Maria de Souza-Fagundes, Tania Maria de Almeida Alves, Nivea Pereira de Sa, Marina Azevedo Souza, Susana Johann ORCID, Luciana Alves Rodrigues dos Santos Lima, Luciana Alves Rodrigues Dos Santos Lima, Souza,Marina Azevedo, Fernanda Fraga Campos, Johann,Susana, Lima,Luciana Alves Rodrigues dos Santos, Isolda Castro Mendes, Campos,Fernanda Fraga and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Lapachol was chemically modified to obtain its thiosemicarbazone and semicarbazone derivatives. These compounds were tested for antimicrobial activity against several bacteria and fungi by the broth microdilution method. The thiosemicarbazone and semicarbazone derivatives of lapachol exhibited antimicrobial activity against the bacteria Enterococcus faecalis and Staphylococcus aureus with minimal inhibitory concentrations (MICs) of 0.05 and 0.10 μmol/mL, respectively. The thiosemicarbazone and semicarbazone derivatives were also active against the pathogenic yeast Cryptococcus gattii (MICs of 0.10 and 0.20 μmol/mL, respectively). In addition, the lapachol thiosemicarbazone derivative was active against 11 clinical isolates of Paracoccidioides brasiliensis , with MICs ranging from 0.01-0.10 μmol/mL. The lapachol-derived thiosemicarbazone was not cytotoxic to normal cells at the concentrations that were active against fungi and bacteria. We synthesised, for the first time, thiosemicarbazone and semicarbazone derivatives of lapachol. The MICs for the lapachol-derived thiosemicarbazone against S. aureus, E. faecalis, C. gattii and several isolates of P. brasiliensis indicated that this compound has the potential to be developed into novel drugs to treat infections caused these microbes.